Asked by: Baroness Hayman of Ullock (Labour - Life peer)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health, how many current vacancies there are for (a) doctors, (b) nurses) and (c) ancillary healthcare staff at the North Cumbria University Hospitals NHS Trust.
Answered by Philip Dunne
The information is not available in the format requested.
Health Education England latest estimates of staff shortages and the plan for tackling these issues is set out in their ‘Facing the Facts, Shaping the Future, A draft health and care workforce strategy for England to 2027’ published this month.
NHS Digital publishes the number of vacancies that are advertised on NHS Jobs, the dedicated online recruitment service for the National Health Service. However, as the basis of the figures is the number of vacancies advertised for the first time in each given month, it is not possible to determine from these figures the number of vacancies live at any given point in time. The figures only cover those vacancies advertised via NHS Jobs, and it is not always possible to determine how many posts are associated with any given advertisement. The published figures are at the Health Education England region and do not go to the level of individual trusts.
The latest figures are available at the following link:
Asked by: Baroness Hayman of Ullock (Labour - Life peer)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health, how many (a) doctors, (b) nurses and (c) ancillary healthcare staff have been recruited by the North Cumbria University Hospitals NHS Trust in each of the last five years.
Answered by Philip Dunne
NHS Digital publishes workforce statistics and the following table shows the number of joiners and leavers for Hospital and Community Health Service (HCHS) doctors, nurses, and ancillary healthcare staff at North Cumbria University Hospitals National Health Service Trust at 31 August each year from 2012 to 2017.
NHS HCHS: Doctors, nurses and ancillary healthcare staff as at 31 August each specified year (Headcount).
| August 2012-13 | August 2013-14 | August 2014-15 | August 2015-16 | August 2016-17 |
HCHS doctors |
|
|
|
|
|
Joiners | 157 | 148 | 127 | 140 | 183 |
Leavers | 146 | 174 | 135 | 145 | 152 |
Nurses |
|
|
|
|
|
Joiners | 156 | 140 | 121 | 123 | 136 |
Leavers | 98 | 136 | 118 | 133 | 143 |
Ancillary healthcare staff |
|
|
|
|
|
Joiners | 14 | 11 | 10 | 25 | 13 |
Leavers | 18 | 155 | 9 | 8 | 8 |
Source: NHS Digital workforce statistics
Note:
High leaver figures in the ancillary healthcare staff group between August 2013 and August 2014 are due to recoding of staff in the Trust.
Asked by: Baroness Hayman of Ullock (Labour - Life peer)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health, how many (a) doctors, (b) nurses) and (c) ancillary healthcare staff left their posts at the North Cumbria University Hospitals NHS Trust in each of the last five years.
Answered by Philip Dunne
NHS Digital publishes workforce statistics and the following table shows the number of joiners and leavers for Hospital and Community Health Service (HCHS) doctors, nurses, and ancillary healthcare staff at North Cumbria University Hospitals National Health Service Trust at 31 August each year from 2012 to 2017.
NHS HCHS: Doctors, nurses and ancillary healthcare staff as at 31 August each specified year (Headcount).
| August 2012-13 | August 2013-14 | August 2014-15 | August 2015-16 | August 2016-17 |
HCHS doctors |
|
|
|
|
|
Joiners | 157 | 148 | 127 | 140 | 183 |
Leavers | 146 | 174 | 135 | 145 | 152 |
Nurses |
|
|
|
|
|
Joiners | 156 | 140 | 121 | 123 | 136 |
Leavers | 98 | 136 | 118 | 133 | 143 |
Ancillary healthcare staff |
|
|
|
|
|
Joiners | 14 | 11 | 10 | 25 | 13 |
Leavers | 18 | 155 | 9 | 8 | 8 |
Source: NHS Digital workforce statistics
Note:
High leaver figures in the ancillary healthcare staff group between August 2013 and August 2014 are due to recoding of staff in the Trust.
Asked by: Baroness Hayman of Ullock (Labour - Life peer)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health, what the roles and responsibilities of his Department's Pharmacy Rebalancing Board are.
Answered by Steve Brine
The Rebalancing Medicines Legislation and Pharmacy Regulation Programme Board (the Board) was established to advise the Government and devolved administrations on how best to move from pharmacy practice matters set out in legislation, to an approach based on professional standards in line with other healthcare professionals. The Board is tasked to examine the respective scope of pharmacy legislation and regulation, and the interface between them, with a view to ensuring these are optimally designed to provide safety for users of pharmacy services, facilitating a systematic approach to quality in pharmacy and responsible development of practice and innovation, whilst reducing the burden of unnecessary and inflexible regulations.
The Rebalancing Programme Board’s full terms of reference are published at:
https://www.gov.uk/government/groups/pharmacy-regulation-programme-board
Asked by: Baroness Hayman of Ullock (Labour - Life peer)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health, what assessment his Department has made of the potential patient safety implications of allowing non-pharmacists to supervise the sale and supply of prescription medicines.
Answered by Steve Brine
The Government has not received any recommendations from the Rebalancing Medicines Legislation and Pharmacy Regulation Programme Board to allow non-pharmacists to supervise the sale and supply of prescription medicines. In keeping with its terms of reference, the Rebalancing Programme Board is giving very careful consideration to the supervision of the sale and supply of medicines and the roles of registered pharmacists and registered pharmacy technicians, under the guidance of the four UK Chief Pharmaceutical Officers. Only when the Board has firm proposals will it make recommendations to Ministers and the devolved administrations. Any changes to legislation will be subject to full public consultation, including the completion of an impact assessment, underpinned by a quality systems approach, which maintains patient and public safety.
The Rebalancing Programme Board meets regularly according to business need, having met three times in the last year. Full terms of reference and minutes of the meetings are published at:
https://www.gov.uk/government/groups/pharmacy-regulation-programme-board
Asked by: Baroness Hayman of Ullock (Labour - Life peer)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health, whether he has received policy recommendations from the Pharmacy Rebalancing Board on pharmacy supervision; and what the timetable is for the receipt of further such recommendations.
Answered by Steve Brine
The Government has not received any recommendations from the Rebalancing Medicines Legislation and Pharmacy Regulation Programme Board to allow non-pharmacists to supervise the sale and supply of prescription medicines. In keeping with its terms of reference, the Rebalancing Programme Board is giving very careful consideration to the supervision of the sale and supply of medicines and the roles of registered pharmacists and registered pharmacy technicians, under the guidance of the four UK Chief Pharmaceutical Officers. Only when the Board has firm proposals will it make recommendations to Ministers and the devolved administrations. Any changes to legislation will be subject to full public consultation, including the completion of an impact assessment, underpinned by a quality systems approach, which maintains patient and public safety.
The Rebalancing Programme Board meets regularly according to business need, having met three times in the last year. Full terms of reference and minutes of the meetings are published at:
https://www.gov.uk/government/groups/pharmacy-regulation-programme-board
Asked by: Baroness Hayman of Ullock (Labour - Life peer)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health, how often the Pharmacy Rebalancing Board has met; and whether the minutes of those meetings are publicly available.
Answered by Steve Brine
The Government has not received any recommendations from the Rebalancing Medicines Legislation and Pharmacy Regulation Programme Board to allow non-pharmacists to supervise the sale and supply of prescription medicines. In keeping with its terms of reference, the Rebalancing Programme Board is giving very careful consideration to the supervision of the sale and supply of medicines and the roles of registered pharmacists and registered pharmacy technicians, under the guidance of the four UK Chief Pharmaceutical Officers. Only when the Board has firm proposals will it make recommendations to Ministers and the devolved administrations. Any changes to legislation will be subject to full public consultation, including the completion of an impact assessment, underpinned by a quality systems approach, which maintains patient and public safety.
The Rebalancing Programme Board meets regularly according to business need, having met three times in the last year. Full terms of reference and minutes of the meetings are published at:
https://www.gov.uk/government/groups/pharmacy-regulation-programme-board
Asked by: Baroness Hayman of Ullock (Labour - Life peer)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health, whether it is his Department's policy that rules on pharmacy supervision should be changed to all non-pharmacists to supervise the sale and supply of prescription medicines; and if he will make a statement.
Answered by Steve Brine
The Government has not received any recommendations from the Rebalancing Medicines Legislation and Pharmacy Regulation Programme Board to allow non-pharmacists to supervise the sale and supply of prescription medicines. In keeping with its terms of reference, the Rebalancing Programme Board is giving very careful consideration to the supervision of the sale and supply of medicines and the roles of registered pharmacists and registered pharmacy technicians, under the guidance of the four UK Chief Pharmaceutical Officers. Only when the Board has firm proposals will it make recommendations to Ministers and the devolved administrations. Any changes to legislation will be subject to full public consultation, including the completion of an impact assessment, underpinned by a quality systems approach, which maintains patient and public safety.
The Rebalancing Programme Board meets regularly according to business need, having met three times in the last year. Full terms of reference and minutes of the meetings are published at:
https://www.gov.uk/government/groups/pharmacy-regulation-programme-board
Asked by: Baroness Hayman of Ullock (Labour - Life peer)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health, how many (a) premature deaths and (b) illnesses have been attributed to poor air quality in each of the last 10 years.
Answered by Baroness Blackwood of North Oxford
In 2010 the Committee on the Medical Effects of Air Pollutants published the report “The Mortality Effects of Long-Term Exposure to Particulate Air Pollution in the United Kingdom”, which concluded, using 2008 data, that the 2008 burden of man-made particulate matter air pollution is, an effect on mortality equivalent to nearly 29,000 deaths in the UK.
In 2014 a Public Health England (PHE) report estimated the annual mortality burden attributable to long-term exposure to man-made particulate air pollution as being equivalent to 25,000 deaths in England.
Estimates of the fraction of mortality attributable to long-term exposure to man-made particulate air pollution for local authority areas in England (2010-15) are provided by the Public Health Outcomes Framework indicator 3.01.,available to view here:
http://www.phoutcomes.info/search/air%20pollution#pat/6/ati/102/par/E12000004
PHE has not quantified the number of illnesses attributed to poor air quality for each of the last ten years.
Asked by: Baroness Hayman of Ullock (Labour - Life peer)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health, what estimate he has made of the cost to the public purse of the Success Regime in West, North and East Cumbria.
Answered by Philip Dunne
The Success Regime was launched in June 2015 and is aimed at providing challenge and support to some of the most challenged health and care economies in the country in order to improve the quality and sustainability of services offered to local people. It takes a whole systems-approach to help address long-standing, deep-rooted and systemic issues. The programme will oversee progress from diagnosis of the underlying issues through to implementation of solutions, and aims to build local leadership capacity in order to ensure that improvements made are maintained.
The allocations followed a business case process and were approved by NHS England. The information requested is shown in the following table:
Allocations to the Success Regimes in 2015/16 and 2016/17
Success Regime | 2015/16 | 2016/17 |
Devon Success Regime | £1.4 million | £6.0 million |
Mid and South Essex Success Regime | £900,000 | £5.7 million |
West, North and East Cumbria Success Regime | £1.2 million | £5.0 million |